Family · Pharmaceutical analytical standards
Vortioxetine
A so-called multimodal antidepressant: it blocks serotonin reuptake and also acts on several serotonin receptors. It was approved in 2013, in both the United States and Europe, for major depression in adults. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Among its targets is the 5-HT3 receptor, the same one blocked by anti-nausea medicines such as ondansetron: together with the serotonin transporter, it is the site where it acts most strongly.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
